Efficacy and safety of repaglinide on glycemic control in diabetic patients with chronic renal failure [Diamond study-2]

Trial Profile

Efficacy and safety of repaglinide on glycemic control in diabetic patients with chronic renal failure [Diamond study-2]

Completed
Phase of Trial: Phase II

Latest Information Update: 16 May 2016

At a glance

  • Drugs Repaglinide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms Diamond study-2
  • Most Recent Events

    • 30 Apr 2016 Status changed from recruiting to completed.
    • 16 Nov 2012 New trial record
    • 25 Oct 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top